P1‐378: Age, APOE e4, and ethnic effect on [C‐11]PiB in multinational ADNI studies: direct comparison of J‐ADNI, US‐ADNI and AIBL data
Kenji Ishii(Tokyo Metropolitan Institute of Gerontology), the Alzheimer’s Disease Neuroimaging Initiative, Muneyuki Sakata(Tokyo Metropolitan Institute of Gerontology), Kiichi Ishiwata(Fukushima Medical University), Michio Senda(Kyoto University), Ryozo Kuwano(Tokyo Metropolitan University), Takeshi Iwatsubo(National Center of Neurology and Psychiatry), the Japanese Alzheimer's Disease Neuroimaging Initiative, Keiichi Oda(Tokyo Metropolitan Institute of Gerontology), Kengo Ito(National Center for Geriatrics and Gerontology), Jun Toyohara(Tokyo Metropolitan Institute of Gerontology)
Cited by 3
Related Papers
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Lecanemab in Early Alzheimer’s Disease
|New England Journal of Medicine|2022|5k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
|Nature|2018|1.7k
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease
|The Journal of Prevention of Alzheimer s Disease|2022|1.3k